---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-026364"
form_type: "8-K"
ticker: "ENVB"
cik: "0000890821"
company_name: "Enveric Biosciences, Inc."
filed_at: "2026-05-29T20:13:38+00:00"
generated_at: "2026-05-29T20:15:12.984213+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Enveric shareholders approve reverse stock split, reject increase in authorized shares

## Summary
- Reverse stock split (1:5 to 1:15) approved: 793,344 for, 190,175 against, 8,309 abstentions.
- Authorized share increase to 5B shares rejected: 427,158 for, 555,147 against, 9,523 abstentions.
- Six director nominees elected: Michael Webb, George Kegler, Frank Pasqualone, Marcus Schabacker, Joseph Tucker, Sheila DeWitt.
- Say-on-pay advisory vote passed: 569,552 for, 26,884 against, 5,297 abstentions.
- Ratification of CBIZ CPAs as auditor passed: 960,728 for, 19,347 against, 11,753 abstentions.

## SEC filing metadata
- accession: 0001493152-26-026364
- form_type: 8-K
- ticker: ENVB
- cik: 0000890821
- company_name: Enveric Biosciences, Inc.
- filed_at: 2026-05-29T20:13:38+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/890821/000149315226026364/0001493152-26-026364-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/890821/000149315226026364/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-026364
- JSON: https://secwatch.observer/filing/0001493152-26-026364.json
- Plain text: https://secwatch.observer/filing/0001493152-26-026364.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.